Biogen Told To Pay Genentech $88M After IP Royalties Mistrial

Biogen MA Inc. owes Genentech Inc. more than $88 million in royalties related to expired patents, a California federal judge ruled Tuesday in a rare post-mistrial verdict arrangement....

Already a subscriber? Click here to view full article